Table 4

Predicted mean annual medical expenditures (U.S. $) in 2007 for U.S. youth with ITDM, by DKA and severe hypoglycemia status

Complication statusTotalComponents
OutpatientInpatientDrug
DKA
DKA14,236 ± 3224,886 ± 1486,228 ± 2143,135 ± 56
No DKA8,398 ± 1393,815 ± 62852 ± 903,707 ± 53
Excess DKA5,837 ± 3531,071 ± 1615,376 ± 233−572 ± 75
Excess DKA (by number of episodes)
    1 episode3,554 ± 360793 ± 2113,354 ± 255−504 ± 92
    >1 episode8,455 ± 5291,388 ± 2287,694 ± 390−650 ± 87
Severe hypoglycemia
Severe hypoglycemia12,850 ± 1275,644 ± 2663,166 ± 4523,896 ± 151
No severe hypoglycemia8,970 ± 6423,831 ± 591,522 ± 963,598 ± 38
Excess severe hypoglycemia3,880 ± 6491,813 ± 2641,644 ± 421298 ± 157
Excess severe hypoglycemia (by number of episodes)
    1 episode2,888 ± 7071,488 ± 2651,067 ± 372220 ± 194
    >1 episode5,929 ± 1,3692,478 ± 5223,035 ± 963458 ± 243
  • Data are means ± bootstrap SEs with 100 replications. Excess = the difference between mean medical expenditures for youth with complications and those for youth with no complications. Covariates included in the model are age, sex, census regions, urbanity of residence, health plan, and asthma. The amount of all the excess expenditures was statistically significant (P < 0.05).